Market Indices
Sector Heatmap
HROW — Harrow, Inc. Common Stock
NasdaqHarrow, Inc. Common Stock
- O
- 31.43
- H
- 31.43
- L
- 30.43
- V
- 586.75K
HROW — Latest News & Headlines
10 StoriesHROW News | HARROW INC (NASDAQ:HROW) - ChartMill
HROW News | HARROW INC (NASDAQ:HROW) ChartMill
TYRVAYA is the only FDA-approved nasal spray for dry eye. Harrow acquired its rights outside Japan. - Stock Titan
TYRVAYA is the only FDA-approved nasal spray for dry eye. Harrow acquired its rights outside Japan. Stock Titan
(HROW) Risk Channels and Responsive Allocation - Stock Traders Daily
(HROW) Risk Channels and Responsive Allocation Stock Traders Daily
Insider Confidence In These Growth Stocks For September 2026 - Simply Wall Street
Insider Confidence In These Growth Stocks For September 2026 Simply Wall Street
Biotech ETF XBI Hits an Interest Rate Wall as 40+ Catalysts Approach - TradingView
Biotech ETF XBI Hits an Interest Rate Wall as 40+ Catalysts Approach TradingView
Harrow Health stock falls 1.55 percent despite Q2 growth - AD HOC NEWS
Harrow Health stock falls 1.55 percent despite Q2 growth AD HOC NEWS
Harrow Health stock gets TYRVAYA after USD 30 million deal - AD HOC NEWS
Harrow Health stock gets TYRVAYA after USD 30 million deal AD HOC NEWS
Harrow, Inc. stock gains as market cap nears USD 1.2 billion - AD HOC NEWS
Harrow, Inc. stock gains as market cap nears USD 1.2 billion AD HOC NEWS
Harrow stock highlights 15 ophthalmic studies at AAO - AD HOC NEWS
Harrow stock highlights 15 ophthalmic studies at AAO AD HOC NEWS
Harrow Closes TYRVAYA Acquisition, Expanding Dry Eye Portfolio - TipRanks
Harrow Closes TYRVAYA Acquisition, Expanding Dry Eye Portfolio TipRanks